<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000484118"><TermName>Mithracin</TermName><TermPronunciation>(MITH-ruh-sin)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat some types of testicular cancer. It is also used to treat a higher-than-normal amounts of calcium in the blood or urine. Mithracin binds to DNA and prevents cells from making RNA and proteins. It is a type of antineoplastic antibiotic. Also called mithramycin and plicamycin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000716795" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Mithracin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000716794" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Mithracin&quot;" language="es" id="_4"/><SpanishTermName>Mithracin</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar algunos tipos de cáncer de testículo. Asimismo, se usa para tratar las cantidades anormalmente altas de calcio en la sangre o la orina. Mithracin se une al ADN e impide que las células elaboren ARN y proteínas. Es un tipo de antibiótico antineoplásico. También se llama mitramicina y plicamicina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-05-05</DateFirstPublished><DateLastModified>2008-01-09</DateLastModified></GlossaryTerm>
